Highlights Novogene Co., Ltd.

Equities

688315

CNE1000052X3

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 21/05/2024 am IST			5-day change	1st Jan Change
13.72 ^CNY	-4.66%		-6.92%	-41.22%

12/04	Novogene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
27/02	Novogene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novogene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	12/04	CI
Novogene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02	CI
Novogene Co., Ltd. announces an Equity Buyback for CNY 160 million worth of its shares.	06/02	CI
Novogene Co., Ltd. authorizes a Buyback Plan.	05/02	CI
Novogene Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/23/24	CI
Novogene Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
Novogene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Novogene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
Novogene Announces Deployment of Illumina NovaSeq™ X Plus and PacBio REVIO Sequencing Systems	05/23/05	CI
Novogene Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/22/24	CI
Novogene America Unveils Superpowered Robot Scientist for Autonomously Intelligent NGS Delivery- Falcon II	07/22/07	CI
Novogene Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	10/22/10	CI
Novogene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI
Novogene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
Novogene Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	25/21/25	CI
Beijing Novogene Technology Co. Ltd. cancelled the acquisition of 10 Sequel Systems, so-Seq annotation from Pacific Biosciences of California, Inc..	16/18/16	CI
Pacific Biosciences of California, Inc. and Novogene Corporation to Jointly Develop and Co-Market Novel Applications Based on Sequel Platform	18/17/18	CI
Beijing Novogene Technology Co. Ltd. agreed to acquire 10 Sequel™ Systems, so-Seq™ annotation from Pacific Biosciences of California, Inc..	16/17/16	CI
Novogene and Illumina, Inc. to Co-Develop NGS Diagnostic System for Reproductive Health and Oncology Applications	14/15/14	CI
International Potato Center Announces Partnership with Novogene Bioinformatics Technology to Advance Global Potato Genomics	29/15/29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Novogene Co., Ltd.

Equities

688315

CNE1000052X3

Highlights

Filters